DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 19, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement
Gates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement Post author:GHIAA Admin Post published:November 9, 2022 Post category: Continue ReadingGates Foundation – Novavax, RSV Vaccine Global Access Commitments Agreement
DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 27, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 8, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 8, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Gates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:April 26, 2022 Post category: Continue ReadingGates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement
Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement Post author:GHIAA Admin Post published:September 10, 2021 Post category: Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
Gates Foundation – CureVac, Global Access Commitments Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac, Global Access Commitments Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement